Biotech · Private company
Arena is a wholly owned subsidiary of Pfizer
Track this companyFree. Adds Arena is a wholly owned subsidiary of Pfizer to your Dealase workspace and tells you when its record changes.
Clinical trials92 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials9
- A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative ColitisPHASE2 · RECRUITING · started Dec 16, 2022ClinicalTrials.gov NCT05287126 · fetched Nov 12, 2026
- A Study to Assess the Hemodynamic Effects, Safety, Tolerability, and Pharmacokinetics of Intravenous APD418 in Adult Participants With Heart Failure With Reduced Ejection FractionPHASE2 · TERMINATED · started Dec 28, 2021ClinicalTrials.gov NCT05139615 · fetched Nov 12, 2026
- A Study to Assess the Effect of Oral Temanogrel on Digital Blood Flow in Adult Participants With Raynaud's Phenomenon Secondary to Systemic SclerosisPHASE2 · TERMINATED · started Nov 3, 2021ClinicalTrials.gov NCT04915950 · fetched Nov 12, 2026
- A Study Evaluating the Safety, Tolerability, and Effect on Microvascular Obstruction of Intravenous Temanogrel in Adult Participants Undergoing Percutaneous Coronary InterventionPHASE2 · TERMINATED · started May 20, 2021ClinicalTrials.gov NCT04848220 · fetched Nov 12, 2026
- Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative ColitisPHASE2 · COMPLETED · started Apr 12, 2021ClinicalTrials.gov NCT04607837 · fetched Nov 12, 2026
- A Study to Assess the Safety and Efficacy of Oral Etrasimod in Adult Participants With Eosinophilic EsophagitisPHASE2 · COMPLETED · started Dec 15, 2020ClinicalTrials.gov NCT04682639 · fetched Nov 12, 2026
- Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia AreataPHASE2 · COMPLETED · started Jul 29, 2020ClinicalTrials.gov NCT04556734 · fetched Nov 12, 2026
- A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's DiseasePHASE2_PHASE3 · TERMINATED · started Jan 6, 2020ClinicalTrials.gov NCT04173273 · fetched Nov 12, 2026
- An Extension Study for Treatment of Moderately to Severely Active Ulcerative ColitisPHASE3 · ACTIVE_NOT_RECRUITING · started Sep 5, 2019ClinicalTrials.gov NCT03950232 · fetched Nov 12, 2026